Recovery and refractoriness following hypertonic saline challenge in asthma Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Refractoriness following hypertonic saline challenge attenuates nocturnal asthma Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Montelukast attenuates the airway response to hypertonic saline in patients with moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002
Correlation between the asthma control, bronchial inflammation and airway response to hypoosmotic stimulus Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
Short term tolerance of hypertonic saline aerosol delivered intranasally Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007
Airway responsiveness to hypertonic saline: dose-response slope or PD15? Source: Eur Respir J 2005; 25: 153-158 Year: 2005
Clinical surveys with nebulised hypertonic saline (HS) in CF children Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020
The in vitro effect of nebulised hypertonic saline on human bronchial epithelium Source: Eur Respir J, 51 (5) 1702652; 10.1183/13993003.02652-2017 Year: 2018
Granulocyte markers in hypertonic and isotonic saline-induced sputum of asthmatic subjects Source: Eur Respir J 2004; 24: 1018-1024 Year: 2004
Cough sensitivity to hypertonic saline and dry air hyperventilation are interrelated Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010
Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD Source: Eur Respir J 2003 Dec 01;22(6):926-930 Year: 2003
Oxygen saturation decrease after both isotonic and hypertonic saline inhalation in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 698s Year: 2005
Increased levels of histamine in sputum after inhalation of hypertonic saline in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 24s Year: 2001
Anti-IL17 treatment controls airway asthmatic responses exacerbated by LPS Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017
Hypertonic histamine challenge induced cough in assessing the treatment response to inhaled corticosteroid in asthma Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008
Airway response to deep inhalation (DI) to characterize airway response to methacholine (Mch) in children Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003
Effect of hypertonic and isotonic saline inhalation on inflammatory cells, granulocyte mediators and chemokines in induced sputum of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 792s Year: 2006
Repeated mannitol or NaCl hyperosmolar exposure of bronchial epithelial cells to mimic exercise-induced airways damage Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011
Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Hypertonic saline increases secretory and exudative responsiveness of human nasal airway in vivo Source: Eur Respir J 2003; 21: 308-312 Year: 2003